30-Day Surgical Mortality: Left Ventricular Assist Devices

In 2008, UW Hospital and Clinics received certification for its Left Ventricular Assist Device (LVAD) program. The use of these heart pumps offers hope to patients with end-stage heart failure.


For some patients, these pumps can be a permanent replacement pump. For others, the device is a bridge, carrying patients until their heart heals or a transplant is available.


The graph below shows 30-day surgical mortality rates for patients who have received ventricular assist devices. 

  • Vertical axis: 30-day mortality rate percentages
  • Horizontal axis: Year  
UW Hospital 0.0 5.9 0.0 0.0 24.0 9.1 0.0 6.3


Source: Data analyses of the Society of Thoracic Surgeons National Adult Cardiac Surgery Database.